The global intrauterine devices market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.75% during 2023-2028. More Info:- https://www.imarcgroup.com/intrauterine-devices-market

1. Global Intrauterine
Devices (IUD) Market
Research and Forecast
Report 2023-2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Intrauterine Devices
(IUD) Market: Global Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2023-2028," the global intrauterine devices market size reached
US$ 4.3 Billion in 2022.
Intrauterine devices (IUDs) are small, T-shaped contraceptive devices that are
inserted into the uterus by healthcare professionals to provide long-term birth
control. They are categorized into two main types: hormonal, which release a
small amount of progestin hormone into the uterus, and copper, which release
copper ions to prevent fertilization. The key characteristics of IUDs include
long-term protection, offering several years of contraception, ranging from 3 to
10 years depending on the type, and reversibility, as they can be removed at
any time, allowing for fertility resumption. IUDs also require minimal
maintenance once inserted, with regular check-ups ensuring that the device
remains in place. The features that make IUDs popular include their
effectiveness, with a success rate of over 99%, making them one of the most
reliable contraceptive methods available. Depending on personal needs and
preferences, users have the flexibility to choose between hormonal and copper
IUDs. Additionally, IUDs are generally considered safe, with serious
complications being rare, although there may be some initial discomfort during
insertion. The combination of effectiveness, long-term protection, reversibility,
minimal maintenance, customization options, and safety establishes IUDs as
an attractive and responsible choice for those seeking long-term birth control
without permanent alteration to fertility.
Request for a PDF sample of this report:
https://www.imarcgroup.com/intrauterine -devices-market/requestsample

4. Report Description
Global Intrauterine Devices (IUD) Market Trends:
The increasing focus on family planning and the need for effective, long-term contraceptive methods represent one of the
primary drivers for the growth of the intrauterine devices (IUDs) market. Moreover, intrauterine devices, medical
instruments inserted into the uterus to prevent pregnancy, are instrumental in providing reliable contraception, enhancing
the convenience of reproductive health management. In addition to this, the versatile application of IUDs in diverse
demographic groups, catering to various lifestyle and medical needs, is acting as a catalyst for the market growth.
Besides this, the rising demand for non-invasive contraceptive methods and the preference for options that provide long-
term efficacy without daily attention are contributing to the market growth. Additionally, significant advancements in
medical technology, such as the development of hormone-releasing IUDs and product variants with increased
biocompatibility, are facilitating personalized health care and enhancing user comfort, thereby supporting the market
growth. Alongside this, the increasing integration of patient-centric designs and safety protocols in IUDs, targeted at
maximizing efficacy and minimizing potential side effects, is significantly driving the market growth. Furthermore,
collaborations with healthcare professionals to develop IUDs that meet specific health requirements are fostering market
growth. Other factors, such as increasing investments in sexual and reproductive health education, tailored marketing
showcasing the advantages of intrauterine devices, and the growing importance of accessible and sustainable birth
control solutions, are creating a positive outlook f or the intrauterine devices market across the g lobe.
Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, expanding at a growth
rate (CAGR) of 4.75% during 2023-2028.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/intrauterine-devices-market

5. Report
Segmentation
Breakup by Product:
• Hormonal Intrauterine Device
• Copper Intrauterine Device
Breakup by End-Use:
• Hospitals
• Gynaecology Clinics
• Community Healthcare
• Others
Breakup by Region:
• Europe
• North America
• Asia Pacific
• Middle East and Africa
• Latin America

6. Competitive
Landscape with
Key Players
• Actavis
• Bayer
• Teva Pharmaceuticals
• Allergan
• ANI Pharmaceuticals
• Eurogine
• OCON Medical
• Pregna
• SMB Corporation
• HLL Lifecare
• HRA Pharma
• Besins HealthCare

7. Key Questions
Answered in
the Report
What was the size of the global intrauterine
devices market in 2022?
What is the expected growth rate of the global
intrauterine devices market during 2023-2028?
What are the key factors driving the global
intrauterine devices market?
What has been the impact of COVID-19 on the
global intrauterine devices market?
What is the breakup of the global intrauterine
devices market based on the product?
What are the key regions in the global
intrauterine devices market?
Who are the key players/companies in the
global intrauterine devices market?

8. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Intrauterine Devices (IUD) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product
5.5 Market Breakup by End -Use
5.6 Market Breakup by Region
5.7 Market Forecast
5.8 SW OT Analysis
5.8.1 Overview
5.8.2 Strengths
5.8.3 W eaknesses
5.8.4 Opportunities
5.8.5 Threats
5.9 Value Chain Analysis
5.9.1 Overview
5.9.2 Research and Development
5.9.3 Raw Material Procurement

9. Table of
Contents
5.9.4 Manufacturing
5.9.5 Marketing
5.9.6 Distribution
5.9.7 End-Use
5.10 Porters Five Forces Analysis
5.10.1 Overview
5.10.2 Bargaining Power of Buyers
5.10.3 Bargaining Power of Suppliers
5.10.4 Degree of Competition
5.10.5 Threat of New Entrants
5.10.6 Threat of Substitutes
6 Market Breakup by Product
6.1 Hormonal Intrauterine Device
6.1.1 Mark et Trends
6.1.2 Market Forecast
6.2 Copper Intrauterine Device
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
7 Market Breakup by End-Use
7.1 Hospitals
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Gynaecology Clinics
7.2.1 Market Trends
7.2.2 Mark et Forecast
7.3 Community Healthcare
7.3.1 Mark et Trends
7.3.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/intrauterine -devices-market/toc

10. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

11. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com